Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Stocktwits on MSN
Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale
Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...
Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
Zacks Investment Research on MSN
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...
In his new book, 'Fair Doses,' epidemiologist Seth Berkley discusses what went right -- and wrong -- with COVID vaccine distribution and whether the world is ready if a new pandemic were to strike.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback